Nacubactam has some intrinsic antibacterial activity resulting from PBP2 inhibition [141]. It seems to own high in vivo activity against AmpC-overproducing and Klebsiella pneumoniae et al. Pharmacodynamics of cefepime coupled with tazobactam against clinically appropriate Enterobacteriaceae inside a neutropenic mouse thigh product Up to now, 1 phase three non-inferiority review https://jeffreytyeng.blogzag.com/72800464/the-2-minute-rule-for-av-101